Icrucumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Icrucumab Usage And Synthesis

Uses

Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a human Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors[1].

References

[1] LoRusso PM, et al. Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. Invest New Drugs. 2014 Apr;32(2):303-11. DOI:10.1007/s10637-013-9998-8

Icrucumab(1024603-92-6)Related Product Information

• Emerfetamab
• Levilimab
• Lorigerlimab
• Avdoralimab
• Iscalimab
• Immunoglobulin G1,anti-(human NCA-90 granulocyte cell antigen) (mouse monoclonal IMMU-MN3 g1-chain), disulfide with mousemonoclonal IMMU-MN3 k-chain, dimer (9CI)
• Letolizumab
• Sudubrilimab
• Tuvonralimab
• Mezagitamab